US Oncology Inc

Credit Agreements Filter

EX-4.18
from S-4 45 pages Lien Subordination and Intercreditor Agreement
12/34/56
EX-10.1
from 8-K 129 pages Credit Agreement Dated as of August 26, 2009, Among US Oncology Holdings, Inc. US Oncology, Inc., as Borrower the Lenders Party Hereto, Deutsche Bank Trust Company Americas, as Administrative Agent and Collateral Agent Morgan Stanley Senior Funding, Inc., and Wells Fargo Bank, N.A., as Syndication Agents and Jpmorgan Chase Bank, N.A., as Documentation Agent Deutsche Bank Securities Inc., as Co-Lead Arranger and Joint Bookrunner J.P. Morgan Securities Inc., as Co-Lead Arranger and Joint Bookrunner Morgan Stanley Senior Funding, Inc., as Co-Lead Arranger and Joint Bookrunner Wells Fargo Securities, LLC, as Co-Lead Arranger and Joint Bookrunner
12/34/56
EX-10.1
from 8-K 10 pages Amendment No. 7 to the Credit Agreement
12/34/56
EX-10.1
from 8-K 12 pages Amendment No.6 to the Credit Agreement Dated as of August 20, 2004
12/34/56
EX-10.2
from 8-K 14 pages Amendment No. 5 to the Credit Agreement
12/34/56
EX-10.4
from 8-K 10 pages Fourth Amendment to Credit Agreement
12/34/56
EX-10.1
from 8-K 8 pages Amendment No. 2 Dated as of November 15, 2005, to the Credit Agreement
12/34/56
EX-10.1
from 8-K 9 pages Amendment No. 1 Dated as of March 17, 2005 (This “Amendment”), to the Credit Agreement (The “Credit Agreement”) Dated as of August 20, 2004, Among US Oncology Holdings, Inc.(“holdings”), US Oncology, Inc. (The “Borrower”), the Lenders Party Thereto, Jpmorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent, Wachovia Bank, National Association, as Syndication Agent, and Citicorp North America, Inc., as Documentation Agent. A. Pursuant to the Credit Agreement, the Lenders and the Issuing Bank Have Extended Credit to the Borrower, and Have Agreed to Extend Credit to the Borrower, in Each Case Pursuant to the Terms and Subject to the Conditions Set Forth Therein. B. the Borrower Has Requested That the Lenders Agree to Amend Certain Provisions of the Credit Agreement as Set Forth Herein. C. the Undersigned Lenders Are Willing So to Amend the Credit Agreement, Pursuant to the Terms and Subject to the Conditions Set Forth Herein. D. Capitalized Terms Used and Not Otherwise Defined Herein Shall Have the Meanings Assigned Thereto in the Credit Agreement, as Amended Hereby. Accordingly, in Consideration of the Mutual Agreements Herein Contained and Other Good and Valuable Consideration, the Sufficiency and Receipt of Which Are Hereby Acknowledged, and Subject to the Conditions Set Forth Herein, the Parties Hereto Agree as Follows: Section 1. Amendment of Section 1.01. Section 1.01 of the Credit Agreement Is Hereby Amended as Follows: (A) by Inserting the Definitions of the Following Terms in the Appropriate Alphabetical Order
12/34/56
EX-10.1
from S-4 114 pages Credit Agreement Dated as of August 20, 2004, Among US Oncology Holdings, Inc. US Oncology, Inc., as Borrower the Lenders Party Hereto, Jpmorgan Chase Bank, as Administrative Agent and Collateral Agent Wachovia Bank, National Association, as Syndication Agent and Citicorp North America, Inc., as Documentation Agent J.P. Morgan Securities Inc., as Co-Lead Arranger and Joint Bookrunner Wachovia Capital Markets, LLC, as Co-Lead Arranger and Joint Bookrunner Citigroup Global Markets Inc., as Arranger
12/34/56
EX-10.17
from 10-K ~10 pages First Amendment to Credit Agreement
12/34/56
EX-10.3
from 10-K ~50 pages Credit Agreement
12/34/56
EX-10.1
from 10-K >50 pages Credit Agreement
12/34/56
EX-10.15
from 10-K405 ~10 pages Second Amendment to Loan Agreement
12/34/56
EX-10.1
from 10-Q >50 pages Fourth Amended and Restated Loan Agreement
12/34/56
EX-10.2
from 10-Q >50 pages Second Amended and Restated Loan Agreement
12/34/56
EX-10.1
from 10-Q ~5 pages Amendment to Amended Loan Agreement
12/34/56